Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer
-
Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Discover and Develop Peptide-conjugated Targeted Antisense Oligonucleotide Therapeutics
-
Rezonate Announces New Integration with CrowdStrike to Stop Identity Breaches
-
Alithya to release fourth quarter and fiscal 2024 financial results on June 13
-
Kick Off Summer Grilling Season with National Beef Burger Day
-
Laser Photonics and Brokk To Co-Host Table at 2024 RadWaste Summit 2.0
-
D-Wave Quantum Set to Join Russell 3000® Index
-
Aruna Bio to Present at BIO International Convention 2024
-
Glaukos Announces Participation in Upcoming Investor Conferences
-
Mobilicom Secures Another Follow-On Order from the U.S. Defense Industry
-
MindMed to Participate in June Conferences
-
Atha Energy Agrees to Terms on $10.7 Million Option Agreement with Riverboat Energy Corporation for Vista Project
-
Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice
-
Orion Group Holdings Set to Join the Russell 3000® Index
-
Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting
-
Merus’ Petosemtamab in Combination with Pembrolizumab Interim Data Demonstrates Robust Response Rate and Favorable Safety Profile in 1L r/m HNSCC
-
Marketing Architects Unveils ‘Smart Targeting’ to Improve CTV Performance
-
9thCO Crafts Next.js-Powered Online Marketplace for Travel Startup RollDeep
-
Ocean Power Technologies Completes Operation with Multiple Unmanned Surface Vehicles for US Government
-
Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June
-
Creative Realities Closes on New Revolving Credit Facility
-
4AIR Business Aviation Analysis Finds Small Changes to Aircraft Routings Could Reduce Environmental Impact
-
FactSet Schedules Third Quarter 2024 Earnings Call
-
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Outdated perceptions and practices fuelling mental health crisis, new Economist Impact study reveals
-
AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024
-
NodThera Announces Appointment of Daniel Swisher as Chief Executive Officer
-
Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference
-
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens
-
Pasithea Therapeutics to Present New Preclinical Data Showing PAS-004 Strongly Inhibits NRAS Cancer Cell Lines and Demonstrates Superior Activity in Xenograft Studies at 2024 ASCO Annual Meeting
-
Quanta Services Announces the Election of Two New Independent Directors and the Appointment of A New Independent Chairman
-
Form 8.3 - [MATTIOLI WOODS PLC - 24 05 2024] - (CGWL)
-
Phreesia Joins the MEDITECH Alliance Program as an Innovator Partner
-
NEXT Golf Tour Champion Jordan Weber Tees It Up on DP World Tour
-
Merck Announces Phase 3 KEYNOTE-522 Trial Met its Overall Survival (OS) Endpoint in Patients With High-Risk Early-Stage Triple Negative Breast Cancer (TNBC)
-
IGT to Optimize Player Convenience and Retail Solutions for Mississippi Lottery via Three-Year Contract Extension
-
Spire Global to Join Russell 3000® Index
-
Waystar Announces Launch of Initial Public Offering
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 24 05 2024] - (CGWL)
-
Atlantica Enters into Agreement to be Acquired by Energy Capital Partners and Co-Investors
-
A Seat at the Table: Mitigating Food Loss With a Smarter Cold Chain
-
BuildDirect Reports First Quarter 2024 Financial Results
-
Moomoo's Parent Company Futu Releases Q1 Earnings Result with US$143.3 Million in Non-GAAP Adjusted Net Income, a 18% Increase QoQ
-
Strawberry Fields REIT Inc. to Hold Annual Shareholder Meeting and Investor Day, Thursday, May 30, 2024 in Ft. Lauderdale, Florida
-
Strawberry Fields REIT to Present at NAREIT’S REITweek Conference in New York City
-
Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC)
-
ITURAN PRESENTS FIRST QUARTER 2024 RESULTS
-
Algonquin Power & Utilities Corp. Announces Its Support for Energy Capital Partners' Proposed Acquisition of Atlantica
-
WYNDHAM HOTELS & RESORTS COMPLETES SUCCESSFUL DEBT REPRICING AND UPSIZING
-
Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis


